TSHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Taysha Gene Therapies, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.94+0.32 (+8.84%)
Close on Oct 19, 2026
- Market cap
- $1.45B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Taysha Gene Therapies's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 1, 2026 | Apr 22, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2025 | Oct 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 3, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 29, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 2, 2025 | Apr 21, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 26, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2024 | Jun 26, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2024 | Jun 18, 2024 | SEC EDGAR |
| Current report | 8-K | May 29, 2024 | May 30, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2024 | Apr 18, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2024 | Mar 19, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 19, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2024 | Jan 10, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 14, 2023 | Dec 20, 2023 | SEC EDGAR |